Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published as Ann Surg Oncol Early Release 10.1245/ASO.2003.03.026 on October 13, 2003

Annals of Surgical Oncology 10:1059-1069 (2003)
© 2003 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pawlik, T. M.
Right arrow Articles by Curley, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pawlik, T. M.
Right arrow Articles by Curley, S. A.
Related Collections
Right arrow Surgery

ORIGINAL ARTICLES

Combined Resection and Radiofrequency Ablation for Advanced Hepatic Malignancies: Results in 172 Patients

Timothy M. Pawlik, MD, MPH, Francesco Izzo, MD, Deborah S. Cohen, MS, Jeffery S. Morris, PhD and Steven A. Curley, MD

From the Departments of Surgery (TMP, SAC) and Biostatistics (DSC, JSM), The University of Texas, M.D. Anderson Cancer Center, Houston, Texas; and the Department of Surgery (FI), The G. Pascale National Cancer Institute, Naples, Italy.

Correspondence: Address correspondence and reprint requests to: Steven A. Curley, MD, The University of Texas MD Anderson Cancer, Department of Surgical Oncology, Box 444, 1515 Holcombe Blvd, Houston, TX 77030; Fax: 713-745-5235; E-mail: scurley{at}mdanderson.org

Background: Resection combined with radiofrequency ablation (RFA) is a novel approach in patients who are otherwise unresectable. The objective of this study was to investigate the safety and efficacy of hepatic resection combined with RFA.

Methods: Patients with multifocal hepatic malignancies were treated with surgical resection combined with RFA. All patients were followed prospectively to assess complications, treatment response, and recurrence.

Results: Seven hundred thirty seven tumors in 172 patients were treated (124 with colorectal metastases; 48 with noncolorectal metastases). RFA was used to treat 350 tumors. Combined modality treatment was well tolerated with low operative times and minimal blood loss. The postoperative complication rate was 19.8% with a mortality rate of 2.3%. At a median follow-up of 21.3 months, tumors had recurred in 98 patients (56.9%). Failure at the RFA site was uncommon (2.3%). A combined total number of tumors treated with resection and RFA >10 was associated with a faster time to recurrence (P = .02). The median actuarial survival time was 45.5 months. Patients with noncolorectal metastases and those with less operative blood loss had an improved survival (P = .03 and P = .04, respectively), whereas radiofrequency ablating a lesion >3 cm adversely impacted survival (HR = 1.85, P = .04).

Conclusions: Resection combined with RFA provides a surgical option to a group of patients with liver metastases who traditionally are unresectable, and may increase long-term survival.

Key Words: Hepatocellular cancer • Liver metastases • Resection • Radiofrequency ablation




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
L. Vigano, A. Ferrero, R. L. Tesoriere, and L. Capussotti
Liver Surgery for Colorectal Metastases: Results after 10 Years of Follow-Up. Long-Term Survivors, Late Recurrences, and Prognostic Role of Morbidity
Ann. Surg. Oncol., September 1, 2008; 15(9): 2458 - 2464.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
M. Chirica, O. Scatton, P.-P. Massault, T. Aloia, B. Randone, B. Dousset, P. Legmann, and O. Soubrane
Treatment of Stage IVA Hepatocellular Carcinoma: Should We Reappraise the Role of Surgery?
Arch Surg, June 1, 2008; 143(6): 538 - 543.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
T. Tsai and J. M. O'Brien
The Future Promise and the Current Reality of Genetic Prognostication in Patients With Uveal Melanoma
Arch Ophthalmol, March 1, 2008; 126(3): 413 - 415.
[Full Text] [PDF]


Home page
RadioGraphicsHome page
M.-h. Park, H. Rhim, Y.-s. Kim, D. Choi, H. K. Lim, and W. J. Lee
Spectrum of CT Findings after Radiofrequency Ablation of Hepatic Tumors
RadioGraphics, March 1, 2008; 28(2): 379 - 390.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
T. M. Pawlik, R. D. Schulick, and M. A. Choti
Expanding Criteria for Resectability of Colorectal Liver Metastases
Oncologist, January 1, 2008; 13(1): 51 - 64.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. T. P. Poon
Radiofrequency Ablation Combined with Resection Enhances Chance for Curative Treatment of Hepatocellular Carcinoma
Ann. Surg. Oncol., December 1, 2007; 14(12): 3299 - 3300.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. Choi, H. K. Lim, J.-W. Joh, S.-J. Kim, M. J. Kim, H. Rhim, Y.-s. Kim, B. C. Yoo, S. W. Paik, and C. K. Park
Combined Hepatectomy and Radiofrequency Ablation for Multifocal Hepatocellular Carcinomas: Long-term Follow-up Results and Prognostic Factors
Ann. Surg. Oncol., December 1, 2007; 14(12): 3510 - 3518.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
P. Kornprat, W. R. Jarnagin, R. P. DeMatteo, Y. Fong, L. H. Blumgart, and M. D'Angelica
Role of Intraoperative Thermoablation Combined With Resection in the Treatment of Hepatic Metastasis From Colorectal Cancer
Arch Surg, November 1, 2007; 142(11): 1087 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Mulier, Y. Ni, L. Frich, F. Burdio, A. L. Denys, J.-F. De Wispelaere, B. Dupas, N. Habib, M. Hoey, M. C. Jansen, et al.
Experimental and Clinical Radiofrequency Ablation: Proposal for Standardized Description of Coagulation Size and Geometry
Ann. Surg. Oncol., April 1, 2007; 14(4): 1381 - 1396.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. J. M. Ruers, J. J. Joosten, B. Wiering, B. S. Langenhoff, H. M. Dekker, T. Wobbes, W. J. G. Oyen, P. F. M. Krabbe, and C. J. A. Punt
Comparison Between Local Ablative Therapy and Chemotherapy for Non-Resectable Colorectal Liver Metastases: A Prospective Study
Ann. Surg. Oncol., March 1, 2007; 14(3): 1161 - 1169.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
E. K. Abdalla, R. Adam, A. J. Bilchik, D. Jaeck, J.-N. Vauthey, and D. Mahvi
Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement
Ann. Surg. Oncol., October 1, 2006; 13(10): 1271 - 1280.
[Full Text] [PDF]


Home page
The OncologistHome page
H. Higgins and D. L. Berger
RFA for Liver Tumors: Does It Really Work?
Oncologist, July 1, 2006; 11(7): 801 - 808.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
T. M. Pawlik, J.-N. Vauthey, E. K. Abdalla, R. E. Pollock, L. M. Ellis, and S. A. Curley
Results of a Single-Center Experience With Resection and Ablation for Sarcoma Metastatic to the Liver
Arch Surg, June 1, 2006; 141(6): 537 - 544.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
F. F. Amersi, A. McElrath-Garza, A. Ahmad, T. Zogakis, D. P. Allegra, R. Krasne, and A. J. Bilchik
Long-term Survival After Radiofrequency Ablation of Complex Unresectable Liver Tumors
Arch Surg, June 1, 2006; 141(6): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
F. H. van Duijnhoven, M. C. Jansen, J. M. C. Junggeburt, R. van Hillegersberg, A. M. Rijken, F. van Coevorden, J. R. van der Sijp, T. M. van Gulik, G. D. Slooter, J. M. Klaase, et al.
Factors Influencing the Local Failure Rate of Radiofrequency Ablation of Colorectal Liver Metastases
Ann. Surg. Oncol., May 1, 2006; 13(5): 651 - 658.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
T. A. Aloia, J.-N. Vauthey, E. M. Loyer, D. Ribero, T. M. Pawlik, S. H. Wei, S. A. Curley, D. Zorzi, and E. K. Abdalla
Solitary Colorectal Liver Metastasis: Resection Determines Outcome
Arch Surg, May 1, 2006; 141(5): 460 - 467.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
C. P. Raut, F. Izzo, P. Marra, L. M. Ellis, J.-N. Vauthey, F. Cremona, P. Vallone, A. Mastro, B. D. Fornage, and S. A. Curley
Significant Long-Term Survival After Radiofrequency Ablation of Unresectable Hepatocellular Carcinoma in Patients with Cirrhosis
Ann. Surg. Oncol., August 1, 2005; 12(8): 616 - 628.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. Elias, L. Sideris, M. Pocard, T. de Baere, C. Dromain, N. Lassau, and P. Lasser
Incidence of Unsuspected and Treatable Metastatic Disease Associated With Operable Colorectal Liver Metastases Discovered Only at Laparotomy (and Not Treated When Performing Percutaneous Radiofrequency Ablation)
Ann. Surg. Oncol., April 1, 2005; 12(4): 298 - 302.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
A. J. Bilchik and M. Faries
Radiofrequency Ablation of Hepatic Malignancies: Inexpensive and Minimally Invasive but Should It Replace Resection?
Ann. Surg. Oncol., November 1, 2003; 10(9): 1002 - 1004.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society of Surgical Oncology.